We serve Chemical Name:6-Benzyl-4-chloro-5,6,7,8-tetrahydropyrido[4,3-d]pyriMidine CAS:914612-23-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![6-Benzyl-4-chloro-5,6,7,8-tetrahydropyrido[4,3-d]pyriMidine](https://a.dearchem.com/CAS2/914612-23-0.png)
Chemical Name:6-Benzyl-4-chloro-5,6,7,8-tetrahydropyrido[4,3-d]pyriMidine
CAS.NO:914612-23-0
Synonyms:MFCD08273929;6-benzyl-4-chloro-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine;6-Benzyl-4-chloro-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine;Pyrido[4,3-d]pyrimidine, 4-chloro-5,6,7,8-tetrahydro-6-(phenylmethyl)-
Molecular Formula:C14H14ClN3
Molecular Weight:259.734
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:396.6±42.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.626
PSA:29.02000
Exact Mass:259.087616
LogP:1.75
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like MFCD08273929 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Pyrido[4,3-d]pyrimidine, 4-chloro-5,6,7,8-tetrahydro-6-(phenylmethyl)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-benzyl-4-chloro-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine Use and application,Pyrido[4,3-d]pyrimidine, 4-chloro-5,6,7,8-tetrahydro-6-(phenylmethyl)- technical grade,usp/ep/jp grade.
Related News: As Natural Capsules did not have access to this manufacturing technology, its R&D centre, which is DSIR approved, had started working on the same since 2018, and has now successfully developed the process including fermentation and chemical synthesis steps, Sunil Mundra, managing director, Natural Capsules told Pharmabiz. 4-(3-bromo-anilino)-5H-thiazol-2-one manufacturers Alexion has been working to push Ultomiris through additional indications ahead of Soliris’ expected loss of exclusivity in 2025. ethyl 2-(2′,2′-dideuteriovinyl)cyclopropanecarboxylate suppliers After a four-year battle over a cancer drug patent, Novartis has been ordered by a California judge to pay a Daiichi Sankyo subsidiary $177.8 million. chloro-methanesulfonic acid-(3-methyl-3H-benzothiazol-2-ylidenehydrazide) vendor & factory.
